메뉴 건너뛰기




Volumn 13, Issue 8, 2015, Pages 1521-1531.e3

Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C

Author keywords

Digestive System; Endocrinology; Epidemiology; Viruses

Indexed keywords

CAFFEINE; COFFEE;

EID: 84937514455     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.01.030     Document Type: Article
Times cited : (38)

References (55)
  • 1
    • 84861018546 scopus 로고    scopus 로고
    • Association of coffee drinking with total and cause-specific mortality
    • Freedman N.D., Park Y., Abnet C.C., et al. Association of coffee drinking with total and cause-specific mortality. NEngl J Med 2012, 366:1891-1904.
    • (2012) NEngl J Med , vol.366 , pp. 1891-1904
    • Freedman, N.D.1    Park, Y.2    Abnet, C.C.3
  • 2
    • 33745127380 scopus 로고    scopus 로고
    • Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study
    • Andersen L.F., Jacobs D.R., Carlsen M.H., et al. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr 2006, 83:1039-1046.
    • (2006) Am J Clin Nutr , vol.83 , pp. 1039-1046
    • Andersen, L.F.1    Jacobs, D.R.2    Carlsen, M.H.3
  • 3
    • 84862299929 scopus 로고    scopus 로고
    • Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants
    • Matsuura H., Mure K., Nishio N., et al. Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. JEpidemiol 2012, 22:160-166.
    • (2012) JEpidemiol , vol.22 , pp. 160-166
    • Matsuura, H.1    Mure, K.2    Nishio, N.3
  • 4
    • 0027092660 scopus 로고
    • Alcohol, smoking, coffee, and cirrhosis
    • Klatsky A.L., Armstrong M.A. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 1992, 136:1248-1257.
    • (1992) Am J Epidemiol , vol.136 , pp. 1248-1257
    • Klatsky, A.L.1    Armstrong, M.A.2
  • 5
    • 0027274899 scopus 로고
    • Unexpected effects of coffee consumption on liver enzymes
    • Casiglia E., Spolaore P., Ginocchio G., et al. Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol 1993, 9:293-297.
    • (1993) Eur J Epidemiol , vol.9 , pp. 293-297
    • Casiglia, E.1    Spolaore, P.2    Ginocchio, G.3
  • 6
    • 0031843679 scopus 로고    scopus 로고
    • Coffee consumption and decreased serum γ-glutamyltransferase and aminotransferase activities among male alcohol drinkers
    • Tanaka K., Tokunaga S., Kono S., et al. Coffee consumption and decreased serum γ-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 1998, 27:438-443.
    • (1998) Int J Epidemiol , vol.27 , pp. 438-443
    • Tanaka, K.1    Tokunaga, S.2    Kono, S.3
  • 7
    • 0033968394 scopus 로고    scopus 로고
    • Effects of coffee consumption against the development of liver dysfunction a 4-year follow-up study of middle-aged Japanese male office workers
    • Nakanishi N., Nakamura K., Suzuki K., et al. Effects of coffee consumption against the development of liver dysfunction a 4-year follow-up study of middle-aged Japanese male office workers. Ind Health 2000, 38:99-102.
    • (2000) Ind Health , vol.38 , pp. 99-102
    • Nakanishi, N.1    Nakamura, K.2    Suzuki, K.3
  • 8
    • 0034908692 scopus 로고    scopus 로고
    • Coffee consumption and serum aminotransferases in middle-aged Japanese men
    • Honjo S., Kono S., Coleman M.P., et al. Coffee consumption and serum aminotransferases in middle-aged Japanese men. JClin Epidemiol 2001, 54:823-829.
    • (2001) JClin Epidemiol , vol.54 , pp. 823-829
    • Honjo, S.1    Kono, S.2    Coleman, M.P.3
  • 9
    • 0038499415 scopus 로고    scopus 로고
    • Coffee intake and mortality from liver cirrhosis
    • Tverdal A., Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol 2003, 13:419-423.
    • (2003) Ann Epidemiol , vol.13 , pp. 419-423
    • Tverdal, A.1    Skurtveit, S.2
  • 10
    • 11144257762 scopus 로고    scopus 로고
    • Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States
    • Ruhl C.E., Everhart J.E. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005, 128:24-32.
    • (2005) Gastroenterology , vol.128 , pp. 24-32
    • Ruhl, C.E.1    Everhart, J.E.2
  • 11
    • 73449136857 scopus 로고    scopus 로고
    • Increased caffeine consumption is associated with reduced hepatic fibrosis
    • Modi A.A., Feld J.J., Park Y., et al. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 2010, 51:201-209.
    • (2010) Hepatology , vol.51 , pp. 201-209
    • Modi, A.A.1    Feld, J.J.2    Park, Y.3
  • 12
    • 33750055230 scopus 로고    scopus 로고
    • Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: a case-control study
    • Ohfuji S., Fukushima W., Tanaka T., et al. Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: a case-control study. Hepatol Res 2006, 36:201-208.
    • (2006) Hepatol Res , vol.36 , pp. 201-208
    • Ohfuji, S.1    Fukushima, W.2    Tanaka, T.3
  • 13
    • 34548297395 scopus 로고    scopus 로고
    • Coffee drinking and hepatocellular carcinoma risk: a meta-analysis
    • Bravi F., Bosetti C., Tavani A., et al. Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 2007, 46:430-435.
    • (2007) Hepatology , vol.46 , pp. 430-435
    • Bravi, F.1    Bosetti, C.2    Tavani, A.3
  • 14
    • 34247633571 scopus 로고    scopus 로고
    • Coffee consumption and risk of liver cancer: a meta-analysis
    • Larsson S.C., Wolk A. Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology 2007, 132:1740-1745.
    • (2007) Gastroenterology , vol.132 , pp. 1740-1745
    • Larsson, S.C.1    Wolk, A.2
  • 15
    • 84885848163 scopus 로고    scopus 로고
    • Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis
    • Bravi F., Bosetti C., Tavani A., et al. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol 2013, 11:1413-1421.
    • (2013) Clin Gastroenterol Hepatol , vol.11 , pp. 1413-1421
    • Bravi, F.1    Bosetti, C.2    Tavani, A.3
  • 16
    • 72949092282 scopus 로고    scopus 로고
    • Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C
    • Freedman N.D., Everhart J.E., Lindsay K.L., et al. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology 2009, 50:1360-1369.
    • (2009) Hepatology , vol.50 , pp. 1360-1369
    • Freedman, N.D.1    Everhart, J.E.2    Lindsay, K.L.3
  • 17
    • 79956132802 scopus 로고    scopus 로고
    • Association of caffeine intake and histological features of chronic hepatitis C
    • Costentin C.E., Roudot-Thoraval F., Zafrani E.S., et al. Association of caffeine intake and histological features of chronic hepatitis C. JHepatol 2011, 54:1123-1129.
    • (2011) JHepatol , vol.54 , pp. 1123-1129
    • Costentin, C.E.1    Roudot-Thoraval, F.2    Zafrani, E.S.3
  • 18
    • 33748117772 scopus 로고    scopus 로고
    • Insulin resistance and HCV: will new knowledge modify clinical management?
    • Negro F. Insulin resistance and HCV: will new knowledge modify clinical management?. JHepatol 2006, 45:514-519.
    • (2006) JHepatol , vol.45 , pp. 514-519
    • Negro, F.1
  • 19
    • 21444448910 scopus 로고    scopus 로고
    • Coffee consumption and risk of type 2 diabetes a systematic review
    • Van Dam R.M., Hu F.B. Coffee consumption and risk of type 2 diabetes a systematic review. JAMA 2005, 294:97-104.
    • (2005) JAMA , vol.294 , pp. 97-104
    • Van Dam, R.M.1    Hu, F.B.2
  • 20
    • 84857444626 scopus 로고    scopus 로고
    • Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males
    • White D.L., Tavakoli-Tabasi S., Kuzniarek J., et al. Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males. Hepatology 2012, 55:759-768.
    • (2012) Hepatology , vol.55 , pp. 759-768
    • White, D.L.1    Tavakoli-Tabasi, S.2    Kuzniarek, J.3
  • 21
    • 84892484308 scopus 로고    scopus 로고
    • Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities
    • Kanwal F., White D.L., Tavakoli-Tabasi S., et al. Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities. Clin Gastroenterol Hepatol 2014, 12:327-333.
    • (2014) Clin Gastroenterol Hepatol , vol.12 , pp. 327-333
    • Kanwal, F.1    White, D.L.2    Tavakoli-Tabasi, S.3
  • 22
    • 0042855872 scopus 로고    scopus 로고
    • International physical activity questionnaire: 12-country reliability and validity
    • Craig C.L., Marshall A.L., Sjöström M., et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003, 35:1381-1395.
    • (2003) Med Sci Sports Exerc , vol.35 , pp. 1381-1395
    • Craig, C.L.1    Marshall, A.L.2    Sjöström, M.3
  • 23
    • 0037126526 scopus 로고    scopus 로고
    • Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
    • (2002) Circulation , vol.106 , pp. 3143-3421
  • 24
    • 13844318240 scopus 로고    scopus 로고
    • Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer
    • Michels K.B., Willett W.C., Fuchs C.S., et al. Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. JNatl Cancer Inst 2005, 97:282-292.
    • (2005) JNatl Cancer Inst , vol.97 , pp. 282-292
    • Michels, K.B.1    Willett, W.C.2    Fuchs, C.S.3
  • 25
    • 33645977193 scopus 로고    scopus 로고
    • The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults
    • Iso H., Date C., Wakai K., et al. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med 2006, 144:554-562.
    • (2006) Ann Intern Med , vol.144 , pp. 554-562
    • Iso, H.1    Date, C.2    Wakai, K.3
  • 26
    • 32144439266 scopus 로고    scopus 로고
    • Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study
    • Halfon P., Bourliere M., Deydier R., et al. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study. Am J Gastroenterol 2006, 101:547-555.
    • (2006) Am J Gastroenterol , vol.101 , pp. 547-555
    • Halfon, P.1    Bourliere, M.2    Deydier, R.3
  • 27
    • 33749138640 scopus 로고    scopus 로고
    • Aprospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C
    • Ngo Y., Munteanu M., Messous D., et al. Aprospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem 2006, 52:1887-1896.
    • (2006) Clin Chem , vol.52 , pp. 1887-1896
    • Ngo, Y.1    Munteanu, M.2    Messous, D.3
  • 28
    • 34548294614 scopus 로고    scopus 로고
    • Fibrotest-Actitest: the biochemical marker of liver fibrosis-the Israeli experience
    • Morali G., Maor Y., Klar R., et al. Fibrotest-Actitest: the biochemical marker of liver fibrosis-the Israeli experience. Isr Med Assoc J 2007, 9:588-591.
    • (2007) Isr Med Assoc J , vol.9 , pp. 588-591
    • Morali, G.1    Maor, Y.2    Klar, R.3
  • 29
    • 0035820265 scopus 로고    scopus 로고
    • Biochemical markersof liver fibrosis in patients with hepatitis C virus infection: a prospective study
    • Imbert-Bismut F., Ratziu V., Pieroni L., et al. Biochemical markersof liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001, 357:1069-1075.
    • (2001) Lancet , vol.357 , pp. 1069-1075
    • Imbert-Bismut, F.1    Ratziu, V.2    Pieroni, L.3
  • 30
    • 34047273737 scopus 로고    scopus 로고
    • The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience
    • Grigorescu M., Rusu M., Neculoiu D., et al. The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience. JGastrointest Liver Dis 2007, 16:31-37.
    • (2007) JGastrointest Liver Dis , vol.16 , pp. 31-37
    • Grigorescu, M.1    Rusu, M.2    Neculoiu, D.3
  • 31
    • 0036906034 scopus 로고    scopus 로고
    • Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial
    • Poynard T., Imbert-Bismut F., Ratziu V., et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. JViral Hepat 2002, 9:128-133.
    • (2002) JViral Hepat , vol.9 , pp. 128-133
    • Poynard, T.1    Imbert-Bismut, F.2    Ratziu, V.3
  • 32
    • 77955337805 scopus 로고    scopus 로고
    • ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure
    • Poynard T., Munteanu M., Ngo Y., et al. ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure. Gastroenterol Clin Biol 2010, 34:388-396.
    • (2010) Gastroenterol Clin Biol , vol.34 , pp. 388-396
    • Poynard, T.1    Munteanu, M.2    Ngo, Y.3
  • 33
    • 83555168316 scopus 로고    scopus 로고
    • Caffeine is protective in patients with non-alcoholic fatty liver disease
    • Birerdinc A., Stepanova M., Pawloski L., et al. Caffeine is protective in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2012, 35:76-82.
    • (2012) Aliment Pharmacol Ther , vol.35 , pp. 76-82
    • Birerdinc, A.1    Stepanova, M.2    Pawloski, L.3
  • 34
    • 84897656243 scopus 로고    scopus 로고
    • Coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection?
    • Chen S., Teoh N.C., Chitturi S., et al. coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection?. JGastroenterol Hepatol 2014, 29:435-441.
    • (2014) JGastroenterol Hepatol , vol.29 , pp. 435-441
    • Chen, S.1    Teoh, N.C.2    Chitturi, S.3
  • 35
    • 84901244524 scopus 로고    scopus 로고
    • Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis
    • Andersen I.M., Tengesdal G., Lie B.A., et al. Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2014, 12:1019-1028.
    • (2014) Clin Gastroenterol Hepatol , vol.12 , pp. 1019-1028
    • Andersen, I.M.1    Tengesdal, G.2    Lie, B.A.3
  • 36
    • 84906790686 scopus 로고    scopus 로고
    • Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis
    • Lammert C., Juran B.D., Schlicht E., et al. Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis. Clin Gastroenterol Hepatol 2014, 12:1562-1568.
    • (2014) Clin Gastroenterol Hepatol , vol.12 , pp. 1562-1568
    • Lammert, C.1    Juran, B.D.2    Schlicht, E.3
  • 37
    • 0028674080 scopus 로고
    • The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study
    • Corrao G., Lepore A.R., Torchio P., et al. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Eur J Epidemiol 1994, 10:657-664.
    • (1994) Eur J Epidemiol , vol.10 , pp. 657-664
    • Corrao, G.1    Lepore, A.R.2    Torchio, P.3
  • 38
    • 33745038932 scopus 로고    scopus 로고
    • Coffee, cirrhosis, and transaminase enzymes
    • Klatsky A.L., Morton C., Udaltsova, et al. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 2006, 166:1190-1195.
    • (2006) Arch Intern Med , vol.166 , pp. 1190-1195
    • Klatsky, A.L.1    Morton, C.2    Udaltsova3
  • 39
    • 79959767330 scopus 로고    scopus 로고
    • Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection
    • White D.L., Richardson P.A., Al-Saadi M., et al. Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection. Dig Dis Sci 2011, 56:1835-1847.
    • (2011) Dig Dis Sci , vol.56 , pp. 1835-1847
    • White, D.L.1    Richardson, P.A.2    Al-Saadi, M.3
  • 40
    • 84897618433 scopus 로고    scopus 로고
    • Coffee has hepatoprotective benefits in Brazilian patients with chronic hepatitis C even in lower daily consumption than in American and European populations
    • Machado S.R., Parise E.R., de Carvalho L. Coffee has hepatoprotective benefits in Brazilian patients with chronic hepatitis C even in lower daily consumption than in American and European populations. Braz J Infect Dis 2014, 18:170-176.
    • (2014) Braz J Infect Dis , vol.18 , pp. 170-176
    • Machado, S.R.1    Parise, E.R.2    de Carvalho, L.3
  • 41
    • 84906789794 scopus 로고    scopus 로고
    • Coffee: a panacea or snake oil for the liver?
    • Kumari R., Kim W.R. Coffee: a panacea or snake oil for the liver?. Clin Gasteroenterol Hepatol 2014, 12:1569-1571.
    • (2014) Clin Gasteroenterol Hepatol , vol.12 , pp. 1569-1571
    • Kumari, R.1    Kim, W.R.2
  • 42
    • 46749091223 scopus 로고    scopus 로고
    • Ecto-5'-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis
    • Peng Z., Fernandez P., Wilder T., et al. Ecto-5'-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis. FASEB J 2008, 22:2263-2272.
    • (2008) FASEB J , vol.22 , pp. 2263-2272
    • Peng, Z.1    Fernandez, P.2    Wilder, T.3
  • 43
    • 84880699422 scopus 로고    scopus 로고
    • Coffee attenuates fibrosis by decreasing the expression of TGF-β and CTGF in a murine model of liver damage
    • Arauz J., Moreno M.G., Cortes-Reynosa P., et al. Coffee attenuates fibrosis by decreasing the expression of TGF-β and CTGF in a murine model of liver damage. JAppl Toxicol 2013, 33:970-979.
    • (2013) JAppl Toxicol , vol.33 , pp. 970-979
    • Arauz, J.1    Moreno, M.G.2    Cortes-Reynosa, P.3
  • 44
    • 53249092406 scopus 로고    scopus 로고
    • Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways
    • Gressner O.A., Lahme B., Rehbein K., et al. Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J Hepatol 2008, 49:758-767.
    • (2008) J Hepatol , vol.49 , pp. 758-767
    • Gressner, O.A.1    Lahme, B.2    Rehbein, K.3
  • 45
    • 50049122662 scopus 로고    scopus 로고
    • Decreased expression of cytochromes P450 1A2, 2E1, and 3A4 and drug transporters Na+-taurocholate-cotransporting polypeptide, organic cation transporter 1, and organic anion-transporting peptide-C correlates with the progression of liver fibrosis in chronic hepatitis C patients
    • Nakai K., Tanaka H., Hanada K., et al. Decreased expression of cytochromes P450 1A2, 2E1, and 3A4 and drug transporters Na+-taurocholate-cotransporting polypeptide, organic cation transporter 1, and organic anion-transporting peptide-C correlates with the progression of liver fibrosis in chronic hepatitis C patients. Drug Metab Dispos 2008, 36:1786-1793.
    • (2008) Drug Metab Dispos , vol.36 , pp. 1786-1793
    • Nakai, K.1    Tanaka, H.2    Hanada, K.3
  • 46
    • 0029904160 scopus 로고    scopus 로고
    • Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species
    • Devasagayam T.P., Kamat J.P., Mohan H., et al. Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species. Biochim Biophys Acta 1996, 1282:63-70.
    • (1996) Biochim Biophys Acta , vol.1282 , pp. 63-70
    • Devasagayam, T.P.1    Kamat, J.P.2    Mohan, H.3
  • 47
    • 0036184947 scopus 로고    scopus 로고
    • Does coffee protect against liver cirrhosis?
    • Gallus S., Tavani A., Negri E., et al. Does coffee protect against liver cirrhosis?. Ann Epidemiol 2002, 12:202-205.
    • (2002) Ann Epidemiol , vol.12 , pp. 202-205
    • Gallus, S.1    Tavani, A.2    Negri, E.3
  • 48
    • 0033863355 scopus 로고    scopus 로고
    • Dietary intake and bioavailability of polyphenols
    • Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. JNutr 2000, 130(Suppl):2073S-2085S.
    • (2000) JNutr , vol.130 , pp. 2073S-2085S
    • Scalbert, A.1    Williamson, G.2
  • 49
    • 0036279253 scopus 로고    scopus 로고
    • Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity
    • Cavin C., Holzhaeuser D., Scharf G., et al. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 2002, 40:1155-1163.
    • (2002) Food Chem Toxicol , vol.40 , pp. 1155-1163
    • Cavin, C.1    Holzhaeuser, D.2    Scharf, G.3
  • 50
    • 0035717849 scopus 로고    scopus 로고
    • The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat
    • Huber W.W., Scharf G., Rossmanith W., et al. The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat. Arch Toxicol 2002, 75:685-694.
    • (2002) Arch Toxicol , vol.75 , pp. 685-694
    • Huber, W.W.1    Scharf, G.2    Rossmanith, W.3
  • 51
    • 0034109403 scopus 로고    scopus 로고
    • Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation
    • Lee C. Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation. Clin Chim Acta 2000, 295:141-154.
    • (2000) Clin Chim Acta , vol.295 , pp. 141-154
    • Lee, C.1
  • 52
    • 33646529840 scopus 로고    scopus 로고
    • Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data
    • Leandro G., Mangia A., Hui J., et al. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 2006, 130:1636-1642.
    • (2006) Gastroenterology , vol.130 , pp. 1636-1642
    • Leandro, G.1    Mangia, A.2    Hui, J.3
  • 53
    • 21344472982 scopus 로고    scopus 로고
    • Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C
    • Hézode C., Roudot-Thoraval F., Nguyen S., et al. Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology 2005, 42:63-71.
    • (2005) Hepatology , vol.42 , pp. 63-71
    • Hézode, C.1    Roudot-Thoraval, F.2    Nguyen, S.3
  • 54
    • 84877111505 scopus 로고    scopus 로고
    • Dose- and gender-dependent interactions between coffee consumption and serum GGT activity in alcohol consumers
    • Danielsson J., Kangastupa P., Laatikainen T., et al. Dose- and gender-dependent interactions between coffee consumption and serum GGT activity in alcohol consumers. Alcohol Alcohol 2013, 48:303-307.
    • (2013) Alcohol Alcohol , vol.48 , pp. 303-307
    • Danielsson, J.1    Kangastupa, P.2    Laatikainen, T.3
  • 55
    • 84875128930 scopus 로고    scopus 로고
    • Gender-dependent histone deacetylases injury may contribute to differences in liver recovery rates of male and female mice
    • Wang Y., Ye F., Ke Q., et al. Gender-dependent histone deacetylases injury may contribute to differences in liver recovery rates of male and female mice. Transplant Proc 2013, 45:463-473.
    • (2013) Transplant Proc , vol.45 , pp. 463-473
    • Wang, Y.1    Ye, F.2    Ke, Q.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.